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We read the recent article “Breast milk pasteurization in de-
veloped countries to reduce HIV transmission. Do the ben-
eﬁts outweigh the risks?” in Infectious Diseases in Obstetrics
and Gynecology with great concern. The authors tested two
paired specimens of heated and unheated breast milk using
HIV RNA quantiﬁcation (NASBA and Roche ULTRA PCR).
T h e yf o u n dn od e c r e a s ei nH I VR N Al e v e l sb e t w e e nt h e
heated and unheated samples and thus concluded there to be
insuﬃcient data to recommend heat treatment as a safe al-
ternative in resource-rich countries. We are particularly con-
cerned that they have misinterpreted their results and that
this confusion may be perpetuated in discussions and poli-
cies around the globe, most importantly in resource-poor re-
gions.
We strongly encourage the authors, editors, and read-
ership of your journal to reinterpret the results presented
since the HIV detection method used by Giles and Mijch
does not diﬀerentiate between active (infectious) and inac-
tive (noninfectious) HIV in breast milk. Our team has been
investigating the safety of heat-treated breast milk as an in-
fant feeding option for mothers in developing countries and
have recently published the results of pilot safety data [2].
We have designed a simple “ﬂash-heat” treatment method
that a mother could use in her home or over a ﬁre, similar to
commercial high-temperature, short-time (HTST) pasteur-
ization. Although the study published by Chantry et al [3]
used a similar heating method and demonstrated destruc-
tion of HIV proviral DNA in HIV-infected breast milk cells
[3], the method used in that report achieved higher milk
temperatures due to smaller milk volumes and Pyrex glass.
In designing a more gentle heating method, we also found,
as reported by Giles and Mijch, no decrease in HIV RNA.
We ascertained, however, that assaying for presence of vi-
ral RNA, as performed by Giles in the above article, is not
an adequate technique for detecting infectious virus in heated
breast milk. Nucleic acid is very resistant to heating, up to
the boiling point of water. It is to be expected that viral nu-
cleic acid will remain postheating and will be detected by
PCR-based assays even after the virus itself is rendered to-
tally incapable of replication due to destruction of vital en-
zyme activities, structural proteins, and membrane struc-
tures due to the heat. We acknowledge that RNA detection
is commonly used for quantiﬁcation of HIV in both plasma
and unheated breast milk. In order to determine the eﬀect of
heat on HIV in breast milk, however, the assay must eﬀec-
tively distinguish between live versus inactivated virus. We
have demonstrated this in our recent pilot work compar-
ing the ﬂash-heat method with Pretoria pasteurization, an-
other simple technique mentioned by Giles and Mijch [4, 5].
W ef o u n dn od e c r e a s ei nc e l l - f r e eH I VR N Aa sd e t e r m i n e d
by TaqMan Real-time RNA PCR in breast milk (Log HIV
RNA (SD) in unheated milk = 8.00(0.03) versus heated milk
= 7.95(0.03)). We recognized the need for an alternative as-
say to accurately assess virus viability and, as traditional co-
culture methods are diﬃcult with breast milk due to the in-
nate antiviral properties of the milk, we chose quantitative
measurement of reverse transcriptase (RT) as a marker for
viable HIV (ExaVir Quantitative Reverse Transcriptase Load2 Infectious Diseases in Obstetrics and Gynecology
Kit, Cavidi, Uppsala Sweden). In contrast to our TaqMan
PCR data from the same samples, we found inactivation of
≥ 3 logs of HIV-1 as detected by enzymatic activity of RT in
postheated samples, with the ﬂash-heat method more eﬀec-
tively eliminating RT than Pretoria pasteurization. We have
subsequently conﬁrmed these results by directly assaying for
infectivity using transactivation of a green ﬂuorescent pro-
tein (GFP) reporter group (data unpublished). Although we
acknowledgethatdetectionofHIVactivityinbreastmilkcan
be challenging, we would encourage the authors to repeat
their work using an appropriate assay.
We recognize the concerns mentioned by the authors
regarding the impact of heat on vitamins, proteins, im-
munoglobulins, and the antimicrobial properties of breast
milk. Low-temperature, long-time (LTLT) heat treatments,
for example, Holder pasteurization, typically preserve nu-
trients less than HTST methods do. We reported pilot data
suggesting limited impact on vitamins and proteins using
ﬂash-heat [2]. Our ongoing study is investigating the above
concerns in-depth and we hope to have this data available in
the near future.
We agree that it is not currently justiﬁable to recommend
heat treatment of HIV-infected breast milk in resource-rich
countries. However, we are concerned that the results, pre-
sented by Giles and Mijch of two heated breast milk sam-
ples demonstrating persistent HIV RNA being interpreted
as “persistent HIV” without further exploration of viral in-
fectivity, may have unwarranted repercussions. We strongly
urge re-consideration of the results in light of our ﬁndings
thatHIV RNAis detectableafterheating withno demonstra-
ble activity of RT, which is necessary for virus to replicate.
Heat treatment of breast milk is a recognized infant feed-
ing option by the World Health Organization for HIV pos-
itive mothers who live in areas where no other alternatives
are available. While we acknowledge that further research
is needed, caution should be used when stating conclusions
that may negatively impact policy makers’ decisions regard-
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